Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agile Therapeutics Inc AGRX

Alternate Symbol(s):  AGXRW

Healthcare
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a... see more

Recent & Breaking News (OTCQB:AGRX)

Agile Therapeutics, Inc. (NASDAQ: AGRX) to Ring the NASDAQ Stock Market Closing Bell

GlobeNewswire August 29, 2014

Agile Therapeutics Reports Second Quarter 2014 Financial Results

GlobeNewswire August 14, 2014

Agile Therapeutics Announces Allowance of Additional Patent Claims for Skinfusion®

PR Newswire July 17, 2014

Agile Therapeutics Joins Russell Microcap® Index

PR Newswire June 30, 2014

Agile Therapeutics Announces Issuance of New Patent for Its Skinfusion® Transdermal Delivery Device

PR Newswire June 20, 2014

Agile Therapeutics to Participate at the Janney Capital Markets Boston Healthcare 1X1 Corporate Access Day

PR Newswire June 18, 2014

Agile Therapeutics Announces Pricing Of Initial Public Offering

PR Newswire May 22, 2014